Cargando…

Diosmetin reduces bone loss and osteoclastogenesis by regulating the expression of TRPV1 in osteoporosis rats

BACKGROUND: Osteoporosis is a systemic skeletal disorder and occurs frequently in postmenopausal women and older men. This study aimed to examine whether diosmetin (DIO) can relieve estrogen deficiency—induced osteoporosis and to explore the underlying mechanisms of this potential effect. METHODS: F...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Song, Huang, Youyi, Chen, Yong, Zhou, Renyi, Yang, Xiaozhong, Zou, Yi, Gao, Daxin, Huang, Hua, Yu, Dongming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661890/ https://www.ncbi.nlm.nih.gov/pubmed/33209892 http://dx.doi.org/10.21037/atm-20-6309

Ejemplares similares

Specific targeting of inflammatory osteoclastogenesis by the probiotic yeast S. boulardii CNCM I-745 reduces bone loss in osteoporosis
por: Madel, Maria-Bernadette, et al.
Publicado: (2023)

Melatonin Inhibits Osteoclastogenesis and Osteolytic Bone Metastasis: Implications for Osteoporosis
por: MacDonald, Iona J., et al.
Publicado: (2021)

Hepatocyte growth factor overexpression promotes osteoclastogenesis and exacerbates bone loss in CIA mice
por: Huang, Chaoming, et al.
Publicado: (2020)

The Ethanol Extracts of Osmanthus fragrans Leaves Ameliorate the Bone Loss via the Inhibition of Osteoclastogenesis in Osteoporosis
por: Seo, Yo-Seob, et al.
Publicado: (2023)

Platinum nanoparticles reduce ovariectomy-induced bone loss by decreasing osteoclastogenesis
por: Kim, Woon-Ki, et al.
Publicado: (2012)

Neuronal TRPV1 activation regulates alveolar bone resorption by suppressing osteoclastogenesis via CGRP
por: Takahashi, Naoki, et al.
Publicado: (2016)

Delphinidin, One of the Major Anthocyanidins, Prevents Bone Loss through the Inhibition of Excessive Osteoclastogenesis in Osteoporosis Model Mice
por: Moriwaki, Sawako, et al.
Publicado: (2014)

Nobiletin-loaded micelles reduce ovariectomy-induced bone loss by suppressing osteoclastogenesis
por: Wang, Yabing, et al.
Publicado: (2019)

Short-Term Hypoxia Accelerates Bone Loss in Ovariectomized Rats by Suppressing Osteoblastogenesis but Enhancing Osteoclastogenesis
por: Wang, Guixin, et al.
Publicado: (2016)

Diosmetin Affects Gene Expression on Human Lung Adenocarcinoma Cells
por: Song, Changshan, et al.
Publicado: (2022)

Longbie capsules reduce bone loss in the subchondral bone of rats with comorbid osteoporosis and osteoarthritis by regulating metabolite alterations
por: Liang, Guihong, et al.
Publicado: (2023)

Amlexanox Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss
por: Zhang, Yong, et al.
Publicado: (2015)

Hydrogel-Mediated Release of TRPV1 Modulators to Fine Tune Osteoclastogenesis
por: Chakraborty, Ranabir, et al.
Publicado: (2022)

Vps35 loss promotes hyperresorptive osteoclastogenesis and osteoporosis via sustained RANKL signaling
por: Xia, Wen-Fang, et al.
Publicado: (2013)

Investigation into the Antihypertensive Effects of Diosmetin and Its Underlying Vascular Mechanisms Using Rat Model
por: Ahmad, Taseer, et al.
Publicado: (2022)

Suppression of Inflammation, Osteoclastogenesis and Bone Loss by PZRAS Extract
por: Li, Liang, et al.
Publicado: (2020)

STAT3-mediated osteogenesis and osteoclastogenesis in osteoporosis
por: Hou, Xiaoli, et al.
Publicado: (2022)

Icaritin ameliorates RANKL-mediated osteoclastogenesis and ovariectomy-induced osteoporosis
por: Huang, Jun-ming, et al.
Publicado: (2023)

QKI deficiency leads to osteoporosis by promoting RANKL-induced osteoclastogenesis and disrupting bone metabolism
por: Du, Tianshu, et al.
Publicado: (2020)

Nitazoxanide, an Antiprotozoal Drug, Reduces Bone Loss in Ovariectomized Mice by Inhibition of RANKL-Induced Osteoclastogenesis
por: Li, Chang-hong, et al.
Publicado: (2021)

Baohuoside I Inhibits Osteoclastogenesis and Protects Against Ovariectomy-Induced Bone Loss
por: Ma, Min, et al.
Publicado: (2022)

Diosmetin exerts cardioprotective effect on myocardial ischaemia injury in neonatal rats by decreasing oxidative stress and myocardial apoptosis
por: Mo, GuoLiang, et al.
Publicado: (2020)

Diosmetin alleviates hypoxia-induced myocardial apoptosis by inducing autophagy through AMPK activation
por: Si, Qijun, et al.
Publicado: (2020)

Ulinastatin Inhibits Osteoclastogenesis and Suppresses Ovariectomy-Induced Bone Loss by Downregulating uPAR
por: Huang, Jun-ming, et al.
Publicado: (2018)

Cilostazol Attenuates Ovariectomy-Induced Bone Loss by Inhibiting Osteoclastogenesis
por: Ke, Ke, et al.
Publicado: (2015)

Bone Loss in Intestinal Inflammation Disease Yields to Osteoclastogenesis Inhibition
por: Strober, Warren
Publicado: (2022)

TMBIM6 deficiency leads to bone loss by accelerating osteoclastogenesis
por: Yi, Sun-Ju, et al.
Publicado: (2023)

Matrine prevents bone loss in ovariectomized mice by inhibiting RANKL-induced osteoclastogenesis
por: Chen, Xiao, et al.
Publicado: (2017)

Calpain Inhibitor Reduces Cancer-induced Bone Pain Possibly Through Inhibition of Osteoclastogenesis in Rat Cancer-induced Bone Pain Model
por: Xu, Jia-Ying, et al.
Publicado: (2015)

miR-21-5p targets SKP2 to reduce osteoclastogenesis in a mouse model of osteoporosis
por: Huang, Yizhen, et al.
Publicado: (2021)

Decreased bone formation and increased osteoclastogenesis cause bone loss in mucolipidosis II
por: Kollmann, Katrin, et al.
Publicado: (2013)

miR-34a Blocks Osteoporosis and Bone Metastasis by Inhibiting Osteoclastogenesis and Tgif2
por: Krzeszinskia, Jing Y., et al.
Publicado: (2014)

Corrigendum: Nitazoxanide, an antiprotozoal drug, reduces bone loss in ovariectomized mice by inhibition of RANKL-induced osteoclastogenesis
por: Li, Chang-hong, et al.
Publicado: (2023)

Pharmacokinetic study of luteolin, apigenin, chrysoeriol and diosmetin after oral administration of Flos Chrysanthemi extract in rats
por: Chen, Zhongjian, et al.
Publicado: (2012)

Corrigendum: Ulinastatin Inhibits Osteoclastogenesis and Suppresses Ovariectomy-Induced Bone Loss by Downregulating uPAR
por: Huang, Jun-ming, et al.
Publicado: (2018)

Myeloid thrombomodulin lectin-like domain inhibits osteoclastogenesis and inflammatory bone loss
por: Cheng, Tsung-Lin, et al.
Publicado: (2016)

Jin-Tian-Ge ameliorates ovariectomy-induced bone loss in rats and modulates osteoblastogenesis and osteoclastogenesis in vitro
por: Shen, Yi, et al.
Publicado: (2022)

Meclizine Prevents Ovariectomy-Induced Bone Loss and Inhibits Osteoclastogenesis Partially by Upregulating PXR
por: Guo, Jiachao, et al.
Publicado: (2017)

Inhibition of c-Kit signaling by diosmetin isolated from Chrysanthemum morifolium
por: Lee, Seong Jin, et al.
Publicado: (2013)

Antioxidant Potential of Diosmin and Diosmetin against Oxidative Stress in Endothelial Cells
por: Wójciak, Magdalena, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qhc9of3ogfro14o6r78eli5gu5